Determining optimal combination regimens for patients with multiple myeloma
Here is an interesting paper from our board member Dr. Helen Moore.
Here is an interesting paper from our board member Dr. Helen Moore.
Our work is funded by grants, by innovators and visionaries who support the ideas of cellular computation for combating disease, and by contributions from the general public, from people like you. Our general fund is the most important fund because it allows us to venture into new areas, and to try out projects which don't receive funds from other sources. Please contribute to our general fund!